September 14, 2017
Lawyers and allied interest groups have long enriched themselves at taxpayers’ expense. But usually, it has been by bringing lawsuits, not defending them.
The Ohio Drug Price Standards Initiative might change that. If passed by voters, it would give its sponsors taxpayer money to hire unnecessary lawyers, if the...
February 7, 2017
Hans Rosling, the Swedish doctor and professor who saved countless lives in the world’s poorest countries (and gave TED talks), has died of pancreatic cancer. In December, Nature had an interesting feature with him, discussing his life’s work.
Rosling was an antidote to uninformed pessimism. As Nature...
January 18, 2017
If all goes according to President-elect Donald Trump’s plan, the next Secretary of the Department of Health and Human Services (HHS) will be Rep. Tom Price. While Price is perhaps best known for his opposition to the Affordable Care...
November 28, 2016
This week on RealClear Radio Hour, Drs. Debra Patt and Kerry Emanuel discuss the politics of cancer care, chaos theory, and climate science.
We open the show with Dr. Debra Patt, practicing oncologist and Vice President of Texas Oncology. Debra explains how the well-intentioned federal 340B Drug Discount Program is actually driving up cancer care costs. With preferred vendor hospitals applying their 30-50% drug discounts to all patients, not just the underserved, industry-wide prices are being forced up to subsidize the program. On the whole, however, she is optimistic about the diagnostic innovations, therapeutic success, and a drastic drop in cancer mortality rates.
September 7, 2016
Democrats in the Senate have blocked a bill that would have provided federal funds to combat the spread of the Zika virus, reports The Hill. As a result, supporters were unable to assemble the 60 votes necessary to end debate and move forward to a vote on final passage...
September 6, 2016
Last Friday, Hillary Clinton announced a new plan to “respond to unjustified price hikes” on certain pharmaceutical drugs. This comes after weeks of public debate over the rising price of the EpiPen, a...
September 5, 2016
In this episode of RealClear Radio Hour, we discuss the fiascos of government overreach and overregulation—on American Indian reservations, in the EpiPen saga, and with political intimidation campaigns.
Naomi Schaefer Riley, New York Post columnist and author of The New Trail of Tears: How Washington Is Destroying American Indians joins me at the top of the hour. Naomi details how federal policies have consigned Native Americans to poverty and contributed to their high rates of suicide, domestic abuse, gang violence, unemployment, and drug and alcohol epidemics. She argues for repealing both stifling tribal regulations and the loophole economy regulatory exemptions, instead allowing for true property rights and access...
August 9, 2016
August 5, 2016
After years of waiting and fighting, the new rules put forth by the U.S. Food and Drug Administration (FDA) on electronic cigarettes and other non-cigarette products go into effect Monday, August 8th, 2016. The rule change, purportedly to protect public health...
July 11, 2016
In this week’s episode of RealClear Radio Hour, we tackle the war on cancer. Disruptive innovators, Stephen Bonner and Paul Davies, confront bureaucracy and big science to put patients first and introduce cutting-edge research.
My first guest this week is Stephen Bonner, Entrepreneur in Residence at Harvard Business School and board member and former president and CEO of the Cancer Treatment Centers of America (CTCA) from 1999 to 2014. Bonner discusses the consumer experience and innovations in health care—from experimental treatments to Right-to-Try legislation. He shares how CTCA was founded to offer patient-centric, integrative care for complex, late-stage cancers, challenging the traditional treatment model designed by and for bureaucrats at the Food and Drug Administration, American...